Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Fibrocell reports full enrollment in histology trial of azficel-T

July 12, 2010

Leo Pharma describes new PDE4 inhibitors for dermatological disorders

July 8, 2010

Capstone continues phase II AZX-100 trial after subset data analysis

July 7, 2010

Galderma discloses new tyrosinase inhibitors

June 29, 2010

Anacor reports on phase IIb trial of AN-2728 in psoriasis

June 17, 2010

Almirall and Basilea join to commercialize Toctino for severe CHE

June 15, 2010

Onset advances COL-177 and COL-179 for skin conditions

June 14, 2010

Can-Fite opens new CF-101 IND with phase II/III trial protocol in psoriasis

June 9, 2010

New phase II data disclosed on simplified Visonac procedure

May 31, 2010

Galderma discloses new melanocortin MC1 receptor ligands

May 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.